EFMC
NVO

Empire Financial Management Company’s Novo Nordisk NVO Stock Holding History

Empire Financial Management Company’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,710
Closed -$1.43M – 212
2025
Q2 		$1.43M Buy
+20,710
New +$1.41M 0.41% 75
2025
Q1 		– Sell
-2,439
Closed -$210K – 203
2024
Q4 		$210K Buy
2,439
+509
+26% +$55K 0.07% 194
2024
Q3 		$230K Sell
1,930
-30
-2% -$4K 0.07% 192
2024
Q2 		$280K Hold
1,960
– – 0.09% 177
2024
Q1 		$252K Hold
1,960
– – 0.08% 185
2023
Q4 		$203K Buy
+1,960
New +$194K 0.08% 190

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Empire Financial Management Company's NVO Position: Q3 2025 in Review

Empire Financial Management Company sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 20,710 shares — an estimated $1.43M sold.

Empire Financial Management Company first reported a position in NVO in Q4 2023 and held it in 6 quarters. The position peaked at $1.43M in Q2 2025. 1,396 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Empire Financial Management Company reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Empire Financial Management Company sold 20,710 Novo Nordisk shares in Q3 2025, an estimated $1.43M.
  • Empire Financial Management Company first reported a position in Novo Nordisk in Q4 2023 and held it in 6 quarters.
  • Empire Financial Management Company's Novo Nordisk position peaked at $1.43M in Q2 2025.
  • 1,396 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Empire Financial Management Company's 13F filing for Q3 2025, filed 14 Nov 2025.